If a dose of a once-weekly GLP-1 medication is missed, patients should follow product-specific guidance
However, starting July 1, 2026, there is an exception: If you are a Medicare beneficiary, the federal Medicare GLP-1 Bridge program does accept a prediabetes diagnosis as a qualifying condition to get weight-loss alternatives like Wegovy or Zepbound for a flat $50 a month, provided you meet the required BMI thresholds
Do not take within 5 hours of bedtime as it may interfere with sleep
Some users feel the effects of a single drink much sooner
Using much smaller amounts than clinical doses to test personal tolerance and reduce side effects
Patient reviews consistently highlight the quality of provider interactions, the depth of the initial evaluation, and the relief of finding a platform that understands menopause-related weight gain